Encompass Health Details Executive Compensation, Governance, and Annual Meeting Proposals
Summary
Encompass Health filed its definitive proxy statement, detailing executive compensation, strong performance-based payouts for 2025, and outlining 2026 compensation adjustments and robust corporate governance practices ahead of its annual meeting.
Key Events
-
Annual Shareholder Meeting Scheduled
The company will hold its 2026 Annual Meeting of Stockholders on Thursday, May 7, 2026, to vote on director elections, auditor ratification, and executive compensation.
-
Strong 2025 Executive Payouts Reflect Performance
Executives received significant performance-based compensation for 2025, with Senior Management Bonus Plan (SMBP) awards at 169.1% of target and Performance Share Unit (PSU) awards at 196.7% of target, driven by strong company results.
-
Key Executive Compensation Increases for 2026
The CEO's base salary will increase to $1.2 million and LTIP target to $6.5 million. The EVP and COO's base salary will increase to $700,000, SMBP target to 95%, and LTIP target to 275%.
-
EVP and COO Promotion with Significant Equity Award
Patrick W. Tuer was promoted to Executive Vice President and Chief Operating Officer, receiving a one-time restricted stock award valued at $700,000.
Analysis
This definitive proxy statement provides comprehensive insights into Encompass Health's corporate governance, executive compensation, and proposals for the upcoming annual shareholder meeting. The filing reveals strong 2025 company performance, which resulted in substantial performance-based payouts for executives, including the CEO. Investors gain critical understanding of the executive incentive structure, which is closely tied to financial and operational metrics. The document also outlines forward-looking adjustments to compensation for 2026, including new performance metrics for the annual bonus plan, signaling evolving strategic priorities. Additionally, the promotion of a key executive with a significant equity award highlights management changes and incentives. The detailed disclosure of robust corporate governance practices and board oversight of various risks, including cybersecurity and sustainability, reinforces the company's commitment to transparency and accountability.
At the time of this filing, EHC was trading at $105.83 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.5B. The 52-week trading range was $92.77 to $127.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.